VC  Longitude Capital

http://www.longitudecapital.com





     Office Locations:

800 El Camino Real, Suite 220
Menlo Park, CA 94025
Phone: 650-854-5700

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.
 

Stages:

  • Early
  • Expansion
  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Longitude Capital Management Co., LLC is a private equity and venture capital firm specializing in investments in all stages of development, from privately-held seed stage to publicly-traded later stage life sciences companies. The firm also invests in PIPEs. It primarily invests in the medical devices, biotechnology, specialty pharmaceuticals including drug-device combinations, and pharmaceutical development sectors. In medical devices, the firm has a preference for early stage companies, and in the case of the biotechnology sector, it prefers to invest in more mature companies. Longitude seeks to invest $10 million to $30 million over the life of each portfolio company, but its initial investment can be much smaller, particularly in early stage opportunities. It prefers to lead or co-lead its investments and requires a seat on the Board of Directors of its portfolio companies. Longitude Capital was founded in 2006 and is based in Menlo Park, California with an additional office in Greenwich, Connecticut.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Silicon Valley Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Andrew ElBardissi M.D. Vice President
    Carolyn Helms Vice President
    David Hirsch M.D., Ph.D. Managing Director
    Doug Foster Managing Director
    Gregory Grunberg M.D. Managing Director

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      04/05/2018


      Poseida Therapeutics


      CA


      $30,500,000


      Series B


      04/03/2018


      Axonics Modulation Technologies


      CA


      $40,100,000


      


      12/18/2017


      Aptinyx


      IL


      $70,000,000


      Series B


      11/15/2017


      Inozyme Pharma


      MA


      $49,000,000


      Series A


      11/08/2017


      Tricida


      CA


      $57,500,000


      Series D


      10/17/2017


      Cydan


      MA


      $34,000,000


      


      07/20/2017


      Amphora Medical


      MN


      $35,500,000


      Series B


     

    Portfolio companies include:


      Allergen Research Corporation
        web link


      ALPHAEON
        web link


      Alphatec Spine
        web link


      Amarin
        web link


      Amphora Medical
        web link


      Aptinyx
        web link


      Aptus Endosystems
        web link


      AqueSys
        web link


      Axonics Modulation Technologies
        web link


      BAROnova
        web link


      Cadence Pharmaceuticals
        web link


      Calhoun Vision
        web link


      CardioDx
        web link


      Civitas Therapeutics
        web link


      Collegium
        web link


      Collegium Pharma
        web link


      Collegium Pharmaceutical
        web link


      Corcept Therapeutics
        web link


      Crown Wheel Partners
        web link


      Cydan
        web link


      Esperion Therapeutics
        web link


      InfaCare Pharmaceutical
        web link


      Inozyme Pharma


      Jazz Pharmaceuticals
        web link


      Kala Pharmaceuticals
        web link


      NxStage
        web link


      NxStage Medical
        web link


      Orbus Therapeutics


      PixelOptics
        web link


      Poseida Therapeutics
        web link


      Practice Fusion
        web link


      Precision Therapeutics
        web link


      Rapid Micro Biosystems
        web link


      Renew
        web link


      Solta Medical
        web link


      SutroVax
        web link


      Sympara
        web link


      Tricida
        web link


      Velicept Therapeutics
        web link


      Velomedix
        web link


      Venus Concept
        web link


      Xanodyne
        web link


      Zavante Therapeutics
        web link


     

    Recent News:


      There is no recent news for Longitude Capital.